212 related articles for article (PubMed ID: 36361544)
1. Neuroprotective Effects of Transferrin in Experimental Glaucoma Models.
Youale J; Bigot K; Kodati B; Jaworski T; Fan Y; Nsiah NY; Pappenhagen N; Inman DM; Behar-Cohen F; Bordet T; Picard E
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361544
[TBL] [Abstract][Full Text] [Related]
2. Pathologically high intraocular pressure disturbs normal iron homeostasis and leads to retinal ganglion cell ferroptosis in glaucoma.
Yao F; Peng J; Zhang E; Ji D; Gao Z; Tang Y; Yao X; Xia X
Cell Death Differ; 2023 Jan; 30(1):69-81. PubMed ID: 35933500
[TBL] [Abstract][Full Text] [Related]
3. Role of hypoxia-inducible factor-1α in preconditioning-induced protection of retinal ganglion cells in glaucoma.
Zhu Y; Zhang L; Gidday JM
Mol Vis; 2013; 19():2360-72. PubMed ID: 24319330
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective Effect of Statins in a Rat Model of Chronic Ocular Hypertension.
Kim ML; Sung KR; Kwon J; Choi GW; Shin JA
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830387
[TBL] [Abstract][Full Text] [Related]
5. Peptains block retinal ganglion cell death in animal models of ocular hypertension: implications for neuroprotection in glaucoma.
Nam MH; Stankowska DL; Johnson GA; Nahomi RB; Pantcheva MB; Nagaraj RH
Cell Death Dis; 2022 Nov; 13(11):958. PubMed ID: 36379926
[TBL] [Abstract][Full Text] [Related]
6. Nobiletin protects retinal ganglion cells in models of ocular hypertension in vivo and hypoxia in vitro.
Wang DD; Gao FJ; Zhang XJ; Hu FY; Xu P; Wu JH
Lab Invest; 2022 Nov; 102(11):1225-1235. PubMed ID: 35804043
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of the cysteinyl leukotriene pathways increases survival of RGCs and reduces microglial activation in ocular hypertension.
Trost A; Motloch K; Koller A; Bruckner D; Runge C; Schroedl F; Bogner B; Kaser-Eichberger A; Strohmaier C; Ladek AM; Preishuber-Pfluegl J; Brunner SM; Aigner L; Reitsamer HA
Exp Eye Res; 2021 Dec; 213():108806. PubMed ID: 34715090
[TBL] [Abstract][Full Text] [Related]
8. Assessment of neuroprotective effects of glutamate modulation on glaucoma-related retinal ganglion cell apoptosis in vivo.
Guo L; Salt TE; Maass A; Luong V; Moss SE; Fitzke FW; Cordeiro MF
Invest Ophthalmol Vis Sci; 2006 Feb; 47(2):626-33. PubMed ID: 16431960
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent retinal ganglion cell loss, microglial activation and blood-retina-barrier tightness in an acute model of ocular hypertension.
Trost A; Motloch K; Bruckner D; Schroedl F; Bogner B; Kaser-Eichberger A; Runge C; Strohmaier C; Klein B; Aigner L; Reitsamer HA
Exp Eye Res; 2015 Jul; 136():59-71. PubMed ID: 26001526
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotective effects of transcription factor Brn3b in an ocular hypertension rat model of glaucoma.
Stankowska DL; Minton AZ; Rutledge MA; Mueller BH; Phatak NR; He S; Ma HY; Forster MJ; Yorio T; Krishnamoorthy RR
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):893-907. PubMed ID: 25587060
[TBL] [Abstract][Full Text] [Related]
11. IOP induces upregulation of GFAP and MHC-II and microglia reactivity in mice retina contralateral to experimental glaucoma.
Gallego BI; Salazar JJ; de Hoz R; Rojas B; Ramírez AI; Salinas-Navarro M; Ortín-Martínez A; Valiente-Soriano FJ; Avilés-Trigueros M; Villegas-Perez MP; Vidal-Sanz M; Triviño A; Ramírez JM
J Neuroinflammation; 2012 May; 9():92. PubMed ID: 22583833
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective and intraocular pressure-lowering effects of (-)Delta9-tetrahydrocannabinol in a rat model of glaucoma.
Crandall J; Matragoon S; Khalifa YM; Borlongan C; Tsai NT; Caldwell RB; Liou GI
Ophthalmic Res; 2007; 39(2):69-75. PubMed ID: 17284931
[TBL] [Abstract][Full Text] [Related]
13. Alpha2 adrenergic modulation of NMDA receptor function as a major mechanism of RGC protection in experimental glaucoma and retinal excitotoxicity.
Dong CJ; Guo Y; Agey P; Wheeler L; Hare WA
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4515-22. PubMed ID: 18566471
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of a dual ET
Kodati B; McGrady NR; Jefferies HB; Stankowska DL; Krishnamoorthy RR
Mol Vis; 2022; 28():165-177. PubMed ID: 36274816
[TBL] [Abstract][Full Text] [Related]
15. Hydrogen sulfide supplement attenuates the apoptosis of retinal ganglion cells in experimental glaucoma.
Huang S; Huang P; Lin Z; Liu X; Xu X; Guo L; Shen X; Li C; Zhong Y
Exp Eye Res; 2018 Mar; 168():33-48. PubMed ID: 29326065
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective Effect of Magnesium Acetyltaurate Against NMDA-Induced Excitotoxicity in Rat Retina.
Lambuk L; Jafri AJ; Arfuzir NN; Iezhitsa I; Agarwal R; Rozali KN; Agarwal P; Bakar NS; Kutty MK; Yusof AP; Krasilnikova A; Spasov A; Ozerov A; Ismail NM
Neurotox Res; 2017 Jan; 31(1):31-45. PubMed ID: 27568334
[TBL] [Abstract][Full Text] [Related]
17. Neuroprotective and Anti-Inflammatory Effects of a Hydrophilic Saffron Extract in a Model of Glaucoma.
Fernández-Albarral JA; Ramírez AI; de Hoz R; López-Villarín N; Salobrar-García E; López-Cuenca I; Licastro E; Inarejos-García AM; Almodóvar P; Pinazo-Durán MD; Ramírez JM; Salazar JJ
Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31443568
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of the endothelin A (ET
McGrady NR; Minton AZ; Stankowska DL; He S; Jefferies HB; Krishnamoorthy RR
BMC Neurosci; 2017 Mar; 18(1):27. PubMed ID: 28249604
[TBL] [Abstract][Full Text] [Related]
20. Etanercept, a widely used inhibitor of tumor necrosis factor-α (TNF-α), prevents retinal ganglion cell loss in a rat model of glaucoma.
Roh M; Zhang Y; Murakami Y; Thanos A; Lee SC; Vavvas DG; Benowitz LI; Miller JW
PLoS One; 2012; 7(7):e40065. PubMed ID: 22802951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
